Pregnancy Related Clinical Trial
— MOM-miOfficial title:
MOM-mi: Exploring the Effectiveness of a 12-week Movement Intervention on Heart Rate Variability and Self-compassion Among New Mothers
NCT number | NCT05403983 |
Other study ID # | 101075 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | August 15, 2022 |
Est. completion date | May 31, 2023 |
Verified date | December 2023 |
Source | University of the Fraser Valley |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This is a mixed-methods randomized controlled trial assessing the effects of an online and in person 12-week movement intervention compared to an education only control group on heart rate variability, self-compassion, psychological well-being, fatigue, exercise self-efficacy, physical activity identity, and body image in postpartum women.
Status | Completed |
Enrollment | 38 |
Est. completion date | May 31, 2023 |
Est. primary completion date | May 31, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 19 Years and older |
Eligibility | Inclusion Criteria: - Women who have given birth to a child within the past 6 months and who are cleared for physical activity by their health care provider. Exclusion Criteria: - Participants who have a medical condition that precludes them passing the Get Active questionnaire - Women not clear for physical activity by a health care provider - Participants who are not able to attend classes at pre-specified times |
Country | Name | City | State |
---|---|---|---|
Canada | University of the Fraser Valley | Chilliwack | British Columbia |
Lead Sponsor | Collaborator |
---|---|
University of the Fraser Valley | Les Mills International |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Heart rate variability | Waking RMSDD heart rate variability (chest strap) | Baseline, 12 weeks | |
Primary | Self compassion | Self-compassion scale, maximum score 125. Minimum score 25. Higher score is a better outcome. | Baseline, 12 weeks, 3 months | |
Secondary | Physical activity | Type, amount and frequency of planned exercise, and walking bouts | Baseline, 12 weeks, 3 months | |
Secondary | Self efficacy | Self-efficacy and barrier to exercise scale. Maximum score of 36. Minimum score of 9. Lower score is a better outcome. | Baseline, 12 weeks, 3 months | |
Secondary | Fear of self-compassion | Fear of self-compassion scale. Maximum score of 60. Minimum score of 0. Lower score is a better outcome. | Baseline, 12 weeks, 3 months | |
Secondary | Fatigue | Multidimensional fatigue inventory scale. Maximum score is 100. Minimum score is 20. Lower score is a better outcome. | Baseline, 12 weeks, 3 months | |
Secondary | Sleep quality | Patient Reported Outcomes Measurement Information System (PROMIS) sleep questionnaire. Maximum score of 40. Minimum score of 8. Lower score is a better outcome. | Baseline, 12 weeks, 3 months | |
Secondary | Perceived stress | Perceived stress scale. Maximum score of 40. Minimum score of 0. Lower score is a better outcome. | Baseline, 12 weeks, 3 months | |
Secondary | Physical activity identify | Athlete identity measurement scale. Maximum score of 49. Minimum score is 7. Higher score is better outcome. | Baseline, 12 weeks, 3 months | |
Secondary | Body image | Body dissatisfaction scale. Maximum score of 48. Minimum score of 8. Lower score is better outcome. | Baseline, 12 weeks, 3 months | |
Secondary | Motivation for exercise | Psychological needs for exercise scale. Maximum score of 55. Minimum score of 11. Higher score is better outcome. | Baseline, 12 weeks, 3 months | |
Secondary | Postpartum depression | Edinburgh postnatal depression scale. Maximum score is 30. Minimum score is 0. Lower score is better outcome. | Baseline, 12 weeks, 3 months | |
Secondary | Anxiety | State-trait anxiety scale. Maximum score of 80. Minimum score of 20. Higher score is better outcome. | Baseline, 12 weeks, 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05017974 -
Research on Improving Sleep During Pregnancy
|
N/A | |
Completed |
NCT03284515 -
Vaccination In Pregnancy Gene Signature: VIP Signature Study
|
||
Recruiting |
NCT05969795 -
Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support
|
Phase 1 | |
Recruiting |
NCT06051201 -
Innovation for Small-scale Experiments: ReceptIVFity Test
|
N/A | |
Recruiting |
NCT04828382 -
Prospective Study of Pregnancy in Women With Cystic Fibrosis
|
||
Enrolling by invitation |
NCT04527926 -
STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy
|
N/A | |
Recruiting |
NCT04278651 -
Early Antenatal Support for Iron Deficiency Anemia
|
Phase 4 | |
Recruiting |
NCT04405700 -
Measuring Adverse Pregnancy and Newborn Congenital Outcomes
|
||
Recruiting |
NCT06258902 -
Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
|
||
Completed |
NCT05487196 -
Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia
|
Phase 2 | |
Completed |
NCT03750968 -
Lutein & Zeaxanthin in Pregnancy - Carotenoid Supplementation During Pregnancy: Ocular and Systemic Effects
|
Phase 2 | |
Enrolling by invitation |
NCT06127277 -
Next4You: A Fully Mobile Relationships Based Program for Youth in Foster Care
|
N/A | |
Completed |
NCT05897697 -
Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study
|
||
Recruiting |
NCT05899101 -
The Impact of Opioid and Cannabis Exposure on Fetal Growth
|
||
Completed |
NCT05502510 -
Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
|
||
Completed |
NCT04296396 -
Opioid Prescription After Cesarean Trial
|
Phase 3 | |
Not yet recruiting |
NCT06069869 -
Multiple Micronutrient Supplementation (MMS) Iron Dose Acceptability Crossover Trial
|
Phase 3 | |
Not yet recruiting |
NCT06069856 -
Multiple Micronutrient Supplementation (MMS) IFA- Iron Dose Acceptability Crossover Trial
|
Phase 3 | |
Not yet recruiting |
NCT06163651 -
Evaluating a One-Year Version of the Parent-Child Assistance Program
|
N/A | |
Not yet recruiting |
NCT06079918 -
Multiple Micronutrient Supplementation for Maternal Anemia Prevention in Tanzania
|
Phase 3 |